PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.79%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-28.17%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-10.94%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
7.03%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
-0.18%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
-2.59%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-17.30%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
35.14%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
-9.44%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-18.86%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
29.63%
Interest expense growth above 1.5x CRWV's 1.19%. Michael Burry would check for over-leverage.
-0.48%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-12.49%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
7.50%
Similar EBITDA margin growth to CRWV's 7.69%. Walter Schloss would investigate industry trends.
-12.49%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
5.17%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
81.32%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-11.69%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
6.12%
Pre-tax margin growth below 50% of CRWV's 26.86%. Michael Burry would check for structural issues.
-1.74%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-13.69%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
3.72%
Net margin growth below 50% of CRWV's 25.27%. Michael Burry would check for structural issues.
-13.92%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-12.82%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.50%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.33%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.